RecruitingNot ApplicableNCT07188233

Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With FMR

A Study to Evaluate the Feasibility and Safety of Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With Functional Mitral Regurgitation

Sponsor

HVR Cardio Oy

Enrollment

5 participants

Start Date

Nov 16, 2024

Study Type

INTERVENTIONAL

Conditions

Mitral Valve Regurgitation (Degenerative or Functional)

Summary

Patients with functional mitral regurgitation classified as moderate to severe (3+) or severe (4+) that are symptomatic (NYHA Class II-IV) will be evaluated for treatment using the CathHELIX Transcatheter Mitral Annuloplasty System.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Transcatheter Mitral Valve Repair for people with mitral valve regurgitation (degenerative or functional). The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscatheter Mitral Valve Repair

Mitral valve repair with the CathHELIX Transcatheter Mitral Annuloplasty System in subjects with functional Mitral Regurgitation

Locations(2)

Tbilisi Heart and Vascular Clinic

Tbilisi, Georgia, Georgia

Vilnius University Hospital, Santaros Klinikos, Public Institution

Vilnius, Lithuania, Lithuania

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07188233

Related Trials

TVMR With the INNOVALVE System Trial - Early Feasibility Study

NCT0491998020 locations